Email not displaying properly? View email in your browser
Vertical-Talk Pharma   >  Nanomaterials
>  Novel Nanoprobes
>  Metastatic CRPC
  December 2019   e-Newsletter Advertise | Editorial Calendar  
Catalent
Latest e-book
News
Iktos and Almirall Announce Research...
Organovo and Tarveda Therapeutics Announce...
Press Releases
Pfizer Receives Positive CHMP Opinion...
Immune Therapeutics Announces Plan...
Events
13 - 15 Jan 2020
Biotech Showcase 2020
20 - 21 Jan 2020
Disruptive Technologies In Pharma 2020
Articles
>  A Concise Treatise on Hard and Soft Nanomaterials for Drug Delivery
Chandan Adhikari , Assistant Professor, Lovely Professional University
Most of the conventional (free) drugs suffer from high side effects, poor adsorption, poor solubility, high drug dosing, minimum efficiency, uncontrolled and nonspecific delivery with high cytotoxicity, which limit their uses.These problems can be overcome and toxicity can be reduced if the drugs are delivered through a vehicle that carries the drugs in a controlled way over a certain period of time.The systematic drug delivery system (DDS) become a very fascinating area of research and the last...
Techno Trends
> UC Santa Cruz Researchers Develop Novel Nanoprobes
> Janssen Pharma’s Niraparib Treats Patients with Prostate Cancer
> New Oral Inhibitor Launched to Treat Patients with Histiocytic...
Projects
> Frontage Laboratories Expands Bioanalytical Capacity and Capabilities
> Rentschler Biopharma Starts Bioreactor Facility in US
> Thermo Fisher Scientific Expands its Viral Vectors Facility in US
X-Pure Gelatins for safe micro- and submicron particles applications
  Subscribe  |  e-Book Archives  | Advisory Board  
Follow Us Facebook Twitter linkedin
www.pharmafocusasia.com - Owned by Ochre Media Pvt. Ltd.